Literature DB >> 10418720

Late medical sequelae after therapy for supradiaphragmatic Hodgkin's disease.

A F Abrahamsen1, J H Loge, E Hannisdal, O Nome, M B Lund, H Holte, S Kvaløy.   

Abstract

A total of 221 consecutive early stage Hodgkin's disease (HD) patients were given mantle field irradiation only or in combination with chemotherapy in 1971-1991. In 1994 these patients responded to a mailed self-report questionnaire covering items on late medical symptoms. Of 200 patients (91%) who reported that their thyroid function had been tested, 110 patients (55% of those tested) had thyroid hypofunction at follow-up in 1994. Ninety-five patients (86% of patients with biochemical hypothyreosis) had started hormonal substitution. In 1993 and 1994, 101 of these patients who had received mantle field irradiation in 1980-1988 were called in for interview, clinical examination and thyroid function tests. Eighteen patients (18%) had started hormonal substitution treatment earlier, but 58 (70%) of the other 83 patients were found to have biochemical hypothyreosis. Of the 221 patients who completed the questionnaire, 66 patients (30%) reported dyspnoea on exertion for more than 3 years after treatment, 8 patients (4%) reported a history of myocardial infarction, 6 patients (3%) reported pericardial disease and 25 patients (11%) heart valve disease. Increased expenses incurred for dental care were reported by 106 patients (48%), increasing to 55% when Waldeyer's ring had been irradiated. The consequences of late sequelae after mantle field irradiation for future treatment are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10418720     DOI: 10.1080/028418699432068

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  3 in total

Review 1.  State-of-the-art issues in Hodgkin's lymphoma survivorship.

Authors:  Shrujal S Baxi; Matthew J Matasar
Journal:  Curr Oncol Rep       Date:  2010-11       Impact factor: 5.075

2.  Acute myocardial infarction with normal coronary arteries in a patient with Hodgkin's disease: a late complication of irradiation and chemotherapy.

Authors:  Konstantinos P Letsas; Panagiotis Korantzopoulos; Dimitrios Evangelou; Loukas K Pappas; Fotis Kardaras
Journal:  Tex Heart Inst J       Date:  2006

3.  Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.

Authors:  Mette Seland; Trine Bjøro; Torbjørn Furre; Thomas Schreiner; Jens Bollerslev; Sophie Dorothea Fosså; Jon Håvard Loge; Harald Holte; Cecilie Essholt Kiserud
Journal:  J Cancer Surviv       Date:  2015-03-07       Impact factor: 4.442

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.